Tag: long-acting rFVIII (BAY 94-9027)
Bayer to invest more than 500 million euros for haemophilia A products manufacturing
Bayer, Germany’s biggest pharmaceutical company, has announced that it will invest more than 500 million euros in its Wuppertal and Leverkusen manufacturing sites to...
Featured Article
Driving the future of smart energy: GridBeyond and ABB unveil new white paper on battery storage innovation
As industries adopt cleaner, more intelligent energy solutions, the ability to manage, store, and trade energy efficiently is increasingly vital to sustaining a competitive edge.
